Bausch Health Companies (BHC) Enterprise Value (2009 - 2026)
Bausch Health Companies (BHC) posted Enterprise Value of -$869.0 million for Q2 2026, down 159.4% sequentially from -$335.0 million in Q1 2026, and down 4.45% YoY from -$909.4 million in Q2 2025.
Bausch Health Companies (BHC) Enterprise Value (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Enterprise Value for 18 years, with the latest figure at -$869.0 million in Q2 2026.
- Quarterly Enterprise Value fell 4.45% year-over-year to -$869.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$869.0 million (down 4.45% YoY) and the FY2025 annual result came in at -$394.0 million, down 61.48% from the prior year.
- Enterprise Value slipped to -$869.0 million in Q2 2026 per BHC's latest filing, from -$335.0 million in the prior quarter.
- Over five years, Enterprise Value peaked at $461.0 million in Q3 2022 and troughed at -$2.4 billion in Q1 2022.
- A 5-year average of -$233.7 million and a median of -$118.0 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2024: Enterprise Value soared 170.78% in 2022, then sank 1009.09% in 2024.
- Over 5 years, Enterprise Value stood at $361.0 million in 2022, then plunged by 106.09% to -$22.0 million in 2023, then tumbled by 1009.09% to -$244.0 million in 2024, then sank by 61.48% to -$394.0 million in 2025, then slumped by 120.56% to -$869.0 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$869.0 million, -$335.0 million, and -$394.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Bausch Health Companies | 2.56 Bn | 725.13 Mn | 2.10 Bn | -869.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -869.00 Mn |
| Mar 31, 2026 | -335.00 Mn |
| Dec 31, 2025 | -394.00 Mn |
| Sep 30, 2025 | -419.00 Mn |
| Jun 30, 2025 | -832.00 Mn |
| Mar 31, 2025 | -214.00 Mn |
| Dec 31, 2024 | -244.00 Mn |
| Sep 30, 2024 | 182.00 Mn |
| Jun 30, 2024 | 325.00 Mn |
| Mar 31, 2024 | 186.00 Mn |
| Dec 31, 2023 | -22.00 Mn |
| Sep 30, 2023 | 165.00 Mn |
| Jun 30, 2023 | 346.00 Mn |
| Mar 31, 2023 | 414.00 Mn |
| Dec 31, 2022 | 361.00 Mn |
| Sep 30, 2022 | 461.00 Mn |
| Jun 30, 2022 | -933.00 Mn |
| Mar 31, 2022 | -2.39 Bn |
| Dec 31, 2021 | -510.00 Mn |
| Sep 30, 2021 | -1.84 Bn |